KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vertex Pharmaceuticals (VRTX) Change in Acquisitions & Divestments (2016 - 2025)

Historic Change in Acquisitions & Divestments for Vertex Pharmaceuticals (VRTX) over the last 17 years, with Q4 2025 value amounting to $1.1 billion.

  • Vertex Pharmaceuticals' Change in Acquisitions & Divestments fell 2522.94% to $1.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $5.9 billion, marking a year-over-year increase of 3206.29%. This contributed to the annual value of $5.9 billion for FY2025, which is 3206.29% up from last year.
  • Per Vertex Pharmaceuticals' latest filing, its Change in Acquisitions & Divestments stood at $1.1 billion for Q4 2025, which was down 2522.94% from $1.3 billion recorded in Q3 2025.
  • Vertex Pharmaceuticals' Change in Acquisitions & Divestments' 5-year high stood at $1.8 billion during Q2 2025, with a 5-year trough of $47.2 million in Q4 2021.
  • Over the past 5 years, Vertex Pharmaceuticals' median Change in Acquisitions & Divestments value was $285.5 million (recorded in 2023), while the average stood at $631.1 million.
  • In the last 5 years, Vertex Pharmaceuticals' Change in Acquisitions & Divestments tumbled by 8135.72% in 2021 and then skyrocketed by 132100.0% in 2024.
  • Vertex Pharmaceuticals' Change in Acquisitions & Divestments (Quarter) stood at $47.2 million in 2021, then skyrocketed by 925.64% to $484.1 million in 2022, then crashed by 54.95% to $218.1 million in 2023, then surged by 569.51% to $1.5 billion in 2024, then fell by 25.23% to $1.1 billion in 2025.
  • Its Change in Acquisitions & Divestments stands at $1.1 billion for Q4 2025, versus $1.3 billion for Q3 2025 and $1.8 billion for Q2 2025.